Logitech Files Form 10-Q for Fiscal 2027 Second Quarter
Logitech International filed its second-quarter fiscal 2027 Form 10-Q with the SEC on October 28, 2026.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
30 results loaded, newest first. More results are available. The latest changes are still being indexed. Try again shortly for updated results.
Anthropic Files for Nasdaq IPO Under Ticker ANT
Anthropic has formalized its upcoming IPO filing with the SEC and plans to list on Nasdaq under the name ANT.
Anthropic Files S-1 for Proposed Nasdaq IPO
Anthropic says it plans to list Class A common stock on the Nasdaq Global Select Market under the symbol ANT and has filed a Form S-1 registration statement with the SEC.
Adobe and NVIDIA Expand Collaboration to Speed Agentic Creation
For best results when printing this announcement, please click on link below: Adobe and NVIDIA Expand Collaboration to Speed Agentic Creation Adobe is expanding its collaboration with NVIDIA to optimize its flagship tools including Adobe Photoshop, Premiere, Substance 3D, Frame.io and Brand Concierge, delivering faster
AEye Reports Q2 2026 Results: Full Earnings Call Transcript
AEye (NASDAQ: LIDR ) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. The full earnings call is available at Summary AEye Inc reported signifi
Dropbox Reports Q2 Results, Announces $900 Million Buyback Authorization
Dropbox reported positive year-over-year revenue growth, added 96,000 paying users for a third consecutive quarter and posted a 39.7% non-GAAP operating margin. The company authorized a new $900 million share repurchase program and forecast fiscal 2026 revenue in a stated range.
Sunshine Biopharma files 8-K on placement agreement
Sunshine Biopharma said it entered into a placement agent agreement with Aegis Capital Corp. for a best efforts public offering that closed Oct. 9. The company said gross proceeds were about $6 million before fees and expenses.
Artelo Biosciences Files 8K - Other Events >ARTL
Artelo Biosciences Inc. (ARTL) filed a Form 8K - Other Events - with the U.S Securities and Exchange Commission on October 09, 2026. On July 22, 2026, the Securities and Exchange Commission (the "SEC") approved The Nasdaq Stock Market LLC's ("Nasdaq") new listing compliance rule that requires listed companies to mainta
T Stamp files 8-K on equity distribution agreement
T Stamp said it entered into an equity distribution agreement with Maxim Group LLC under which it may sell shares of common stock from time to time. The ATM prospectus covers up to $5,323,474 of stock sales.
Evernorth Holdings files 8-K on share voting control
Evernorth Holdings said RippleWorks will share disposition and voting control of 3,945,856 shares of Pubco Class A common stock. The filing also outlines related ownership and trading details tied to the business combination.
BioRestorative Therapies files 8-K on director appointment
BioRestorative Therapies said its board appointed Donald J. Currie as a Class I director, effective immediately, to fill a vacancy. It also named him to the Nominating and Corporate Governance Committee and the Compensation Committee.
Gen Digital files 8-K on board appointment
Gen Digital said its board appointed Talbott Roche as a director effective immediately on October 6, 2026. The company said Roche is independent under Nasdaq listing standards and will receive the standard director compensation package.
Lunai Bioworks files 8-K seeking Nasdaq trading suspension
Lunai Bioworks said it filed an 8-K asking Nasdaq to immediately suspend trading in its common stock while the exchange and regulators review trading records tied to pending litigation. The company said the request does not itself halt trading and Nasdaq has not decided whether to act.
TruGolf files 8-K on financing, preferred stock terms
TruGolf Holdings filed an 8-K detailing exchange and exercise agreements tied to its Series A and Series B preferred securities, along with the terms of newly designated Series B preferred stock.
Outlook Therapeutics names Greg DiPasquale chief commercial officer
Outlook Therapeutics appointed Greg DiPasquale chief commercial officer. He will lead commercialization efforts for LYTENAVA as the company prepares a U.S. launch before the end of 2026.
Iron Horse files 8-K on updated merger presentation
Iron Horse Acquisition II said it filed an 8-K and attached an updated investor presentation for its previously announced business combination with Electra Vehicles. The filing also points readers to the related S-4 and proxy materials for the proposed deal.
authID files Form 8-K on offering, warrants and debt
authID filed a Form 8-K that discusses an offering, warrant exercises, potential repayment or refinancing of debentures, and Nasdaq compliance efforts. The report also outlines forward-looking risks tied to liquidity, registration effectiveness and listing status.
authID files 8-K on unregistered equity sales
authID Inc. said it filed an 8-K covering unregistered sales of debentures, warrants and placement agent warrants in a private placement. The filing also says the instruments were offered under a securities-law exemption and sets out related conversion and exercise details.
authID Files 8K - Entry Into Definitive Agreement -2
In connection with the Offering, the holders of the April 2026 Debentures consented to the Offering and to the pari passu ranking of the Debentures and the related security interests, waived any right to repayment of the April 2026 Debentures from the proceeds of the Offering, and agreed to extend the maturity date of
Digital Asset Acquisition files 8-K on business combination
Digital Asset Acquisition Corp. filed an 8-K disclosing that it and Titan issued a press release on their proposed business combination. The company said shareholders will later vote on the deal after a Form S-4 and proxy statement/prospectus are filed.
Digital Asset Acquisition Files 8-K on merger agreement
Digital Asset Acquisition Corp. said it entered into a merger agreement with Titan Strategics Holdings on Oct. 7 and filed the deal in an 8-K on Oct. 8. The agreement contemplates DAAQ's domestication as Renaissance Nuclear, Inc. and the acquisition of Titan for a $250 million base purchase price.
FibroBiologics Files 8K - Entry Into Definitive Agreement >FBLG
FibroBiologics Inc. (FBLG) filed a Form 8K - Entry Into a Definitive Agreement - with the U.S Securities and Exchange Commission on October 08, 2026. On October 7, 2026, FibroBiologics, Inc. (the "Company") entered into a securities purchase agreement (the "SPA") with Peak One Opportunity Fund, L.P. ("Peak One"), pursu
Twin Vee PowerCats files merger agreement 8-K
Twin Vee PowerCats filed an 8-K disclosing an amended and restated merger agreement with USFM Corporation. The agreement outlines a two-step merger structure, consideration terms and possible termination fees.
Law firm files class action against Beta Bionics
Schall, Brown & Schwartz said it filed a federal securities class action against Beta Bionics and certain executives over claims tied to the company’s iLet insulin pump and FDA reporting. Investors have until Nov. 3, 2026, to seek appointment as lead plaintiff.
NVIDIA commits $1 billion to U.S. science research
NVIDIA said it will commit $1 billion over five years to support U.S. science, including quantum computing, healthcare and energy security. The company said the effort is part of its collaboration with the Genesis Mission and U.S. research institutions.
Charlton Aria Acquisition files 8-K on business combination
Charlton Aria Acquisition said it filed an 8-K and attached investor materials for its previously announced business combination with KQC Quantum. The company said a joint investor webcast is scheduled for 10:30 a.m. Eastern on Oct. 8.
Quantum X Labs files U.S. patent application for quantum cooling tech
Quantum X Labs said its subsidiary filed a U.S. patent application for structured-beam laser technology used to cool, manipulate and transport neutral atoms in its cold-atom quantum computing program.
Quantum X Labs files U.S. patent application for atom-cooling tech
Quantum X Labs said its subsidiary filed a U.S. patent application for structured-beam laser technology used to cool, manipulate and transport neutral atoms in its cold-atom quantum computing program.
Scienture files 8-K on reverse stock split press release
Scienture Holdings said it filed a Form 8-K and attached a September 30 press release announcing a reverse stock split.
Scienture Holdings files 8-K on reverse split
Scienture Holdings said it filed a Form 8-K on a 1-for-25 reverse stock split effective Oct. 5. The split was done to help regain compliance with Nasdaq's minimum bid-price requirement.